Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:56:30.151Z.
Calculation as of: 2026-10-06T14:56:30.151Z.
Quote observation: 2026-10-06T14:55:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 80308b770ced1bdfd1e00e86669fc95a739831df2c659c0b91f47c7a41a76c0c
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Cue Biopharma, Inc.
Market Cap
$173.89M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.77M
Operating Cash Flow Yield
N/A
TTM Avg
13.87%
3Y Avg
13.87%
5Y Avg
13.87%
Market Cap
$172.18M
Operating Cash Flow Yield
N/A
TTM Avg
0.62%
3Y Avg
0.62%
5Y Avg
0.62%
Market Cap
$177.78M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.41M
Operating Cash Flow Yield
10.88%
TTM Avg
9.90%
3Y Avg
5.86%
5Y Avg
5.29%
Market Cap
$179.09M
Operating Cash Flow Yield
N/A
TTM Avg
11.12%
3Y Avg
9.89%
5Y Avg
9.89%
Market Cap
$168.56M
Operating Cash Flow Yield
18.97%
TTM Avg
12.15%
3Y Avg
6.20%
5Y Avg
6.85%
Market Cap
$180.85M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | $173.89M | N/A | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $172.77M | N/A | 13.87% | 13.87% | 13.87% |
| Precision BioSciences, Inc. (DTIL)vs › | $172.18M | N/A | 0.62% | 0.62% | 0.62% |
| Nkarta, Inc. (NKTX)vs › | $172.07M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $177.78M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $169.41M | 10.88% | 9.90% | 5.86% | 5.29% |
| Journey Medical Corporation (DERM)vs › | $179.09M | N/A | 11.12% | 9.89% | 9.89% |
| Organogenesis Holdings Inc. (ORGO)vs › | $168.56M | 18.97% | 12.15% | 6.20% | 6.85% |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.85M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $165.32M | N/A | 0.52% | 0.52% | 7.75% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
